Added to Your Shopping Cart
Certificate of Analysis
Are you looking for...
You might be interested in...
Type in Product name, Keyword or Catalog number to see suggestions.
Looking for a Certificate of Analysis?
Have your catalog and lot numbers ready and click the link.
Find CoA
Need help? Please contact us
You searched for "natural killer cells"
Too many choices? Use the filter option on the left to narrow your product listing.
-
CompareP5 Primary Cell 384-well Nucleofector™ KitCatalog #: V5SP-5010For high-throughput transfection of primary cells, e.g. HUVEC, when working with the 384-well HT NucleofectorTM System.Sales unit: items
-
CompareP2 Primary Cell 96-well Nucleofector® KitCatalog #: V4SP-2096For medium-throughput transfection of primary cells, e.g. mouse macrophages or NHDF, when working with the 4D-Nucleofector® 96-well Unit.Sales unit: kit
-
CompareP2 Primary Cell 384-well Nucleofector™ KitCatalog #: V5SP-2010For high-throughput transfection of primary cells, e.g. mouse macrophages or human fibroblasts, when working with the 384-well HT NucleofectorTM System.Sales unit: items
-
CompareP5 Primary Cell 384-well Nucleofector™ KitCatalog #: V5SP-5002For high-throughput transfection of primary cells, e.g. HUVEC, when working with the 384-well HT NucleofectorTM System.Sales unit: kit
-
CompareP2 Primary Cell 384-well Nucleofector™ KitCatalog #: V5SP-2002For high-throughput transfection of primary cells, e.g. mouse macrophages or human fibroblasts, when working with the 384-well HT NucleofectorTM System.Sales unit: kit
-
CompareP5 Primary Cell 96-well Nucleofector® KitCatalog #: V4SP-5096
For medium-throughput transfection of primary cells, e.g. HUVEC, when working with the 4D-Nucleofector® 96-well Unit.
Sales unit: kit -
CompareSCBM™ Stromal Cell Growth Basal MediumCatalog #: CC-3204SCBMTM Stromal Cell Basal MediumSales unit: each
-
ComparePro293s™ Serum-free Medium – Chemically Defined for 293 Cells in SuspensionCatalog #: BEBP02-025QPro293s™ Serum-free medium CD for suspension cells, without L-glutamine, phenol red, galactose or Pluronic® F-68, 1 LSales unit: each -
ComparePro293™ a Serum-free Medium – Chemically Defined for 293 Adherent CellsCatalog #: BEBP12-764QPro293™ serum-free medium Chemically Defined for adherent cells, without L-glutamine or phenol red with 0.1% Pluronic® F-68, 1 LSales unit: each
-
CompareRat Brain Striatum AstrocytesCatalog #: R-CPAS-522Cryopreserved ampule of Rat Brain Striatum Astrocytes containing ≥ 1 million cellsSales unit: Ampule
Added to Your Shopping Cart
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay -
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
Product Availability by Store Location
Hours